Dr. Joseph Z. Forstot, MD

Dr. Forstot practices at Pardo Forstot Baca & Alboukrek PA in Boca Raton, Florida.

Dr. Forstot's NPI, 1144323023, was assigned on September 6, 2006. Dr. Forstot graduated from University of Miami, Miller School of Medicine in 1975. Dr. Forstot holds Florida license ME 28962.

Dr. Forstot's primary practice is Pardo Forstot Baca & Alboukrek PA, at 1050 Nw 15th St, Boca Raton, FL 33486 in Palm Beach County. The practice phone is (561) 368-5611.

Dr. Forstot's primary practice is Pardo Forstot Baca & Alboukrek PA in Boca Raton, Florida. Dr. Forstot is also affiliated with Boca Raton Regional Hospital. The medical group on file is Rheumatology Associates of South Florida. Dmand AI also links Dr. Forstot to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Forstot practices, 2 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Forstot's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Forstot is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Forstot's licenses on file in 2 states: Florida and Colorado.

Dmand AI lists arteritis, arthritis, gout, joint pain, lupus, muscle disease, muscle pain, fibromyalgia, and limb pain and osteoporosis among the conditions Dr. Forstot treats.

CMS data shows 216,205 Medicare services from Dr. Forstot across 59 procedure codes in 2024, for 1,216 Medicare patients. Medicare paid $2,358,055 for them. Every service was in an office.

CMS counts 1,216 Medicare patients who saw Dr. Forstot in 2024. The largest group is 75 to 84, with 577 patients. 75% of them have arthritis, and 75% have high cholesterol. 1% are also on Medicaid. Their average risk score is 1.30, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Forstot's median patient age at 73, with 78% women.

In 2024, Dr. Forstot wrote 2,381 Medicare Part D claims for 388 patients. 91% of them were for generic drugs. CMS names the drug for 2,164 of them, across 52 drugs with 11 or more claims each, at $819,332 in total drug cost. In 2023, CMS named 2,048 claims across 55 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Forstot for performance year 2024, reported as part of a group. Dr. Forstot accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 5 papers to Dr. Forstot in 2024. The most frequent topics are Granulomatosis with Polyangiitis. Dr. Forstot's most frequent co-author is Paul A. Overlie, MD.

Dmand AI links Dr. Forstot to 9 clinical trials, 4 of them phase 3 studies. Conditions studied include Arthritis, Rheumatoid, Rheumatic Diseases and Arthritis, Psoriatic. Eli Lilly and Company sponsors the most, 4. Open Payments lists research payments to Dr. Forstot that name 4 trials.

CMS Open Payments shows 1,567 general payments to Dr. Forstot from 50 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. Janssen Pharmaceuticals, Inc paid the most, $4,142. It also lists 24 research payments totaling $12,642 from 2016 to 2020, naming 4 clinical trials.

Dmand AI lists 5 awards for Dr. Forstot, most recently Super Doc in 2012.

Dr. Forstot graduated from University of Miami, Miller School of Medicine in 1975. Dr. Forstot is a member of ACR.

Dr. Forstot is in network with 2 carriers, including Aetna and CMS Medicare. Medicare plans come from the most carriers, 2. Check the plan with the practice before a visit.